Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
works independently under the direction of the Manager of Quality Reporting & Analytics to design and develop reporting solutions, provide complex analysis of clinical data and share accurate, goal
-
recruited on the project. Full information on the two positions is available at https://jobs.ethz.ch/job/view/JOPG_ethz_yFljDVyQe8rGR1wwVL . The first doctoral candidate will work at ETH Zurich. The present
-
the future. https://nusit.nus.edu.sg/ Job Purpose Build intelligent, scalable applications by leveraging AI tools throughout the development lifecycle—from requirements analysis to deployment. Design and
-
, institutional data management, and regulatory compliance. This role oversees the collection, analysis, validation, governance, and reporting of institutional data to support planning, decision-making, and
-
medicine and diagnostics, epidemiology and biology of infection. For more information, please see https://www.scilifelab.se/data-driven/ddls-research-school/ The future of life science is data-driven. Will
-
Modeling and Forecasting. Using tools like Excel to build models that help with projections, scenario analysis, and business decisions. Tracking KPIs and preparing financial reports. Understanding key
-
Posting Summary Logo Posting Number RTF00066PO26 USC Market Title Post Doctoral Fellow Link to USC Market Title https://uscjobs.sc.edu/titles/156387 Business Title (Internal Title) Post Doctoral
-
"Phase-space-inspired numerical methods for high-frequency wave scattering: from semiclassical analysis through numerical analysis to implementation". The design of fast and reliable algorithms
-
the Marie Skłodowska-Curie Actions (MSCA) grant on WindConnect project. The project The WindConnect (wind farm control and integration in sector-coupled power systems https://cordis.europa.eu/project/id
-
biologists in study design, development of bioinformatic pipelines and analysis modules for the analysis and publication of high-throughput omic data from cancer studies including Phase I / II or III clinical